Amarin Corp Plcuk (AMRN) Operating Expenses (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Operating Expenses of $29.1 million for Q1 2026, down 30.52% year-over-year from $41.9 million in Q1 2025, and down 1.33% quarter-over-quarter from $29.5 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Operating Expenses (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Operating Expenses data on file, last reported at $29.1 million in Q1 2026.

  • Operating Expenses for Q1 2026 came in at $29.1 million, down 30.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $158.3 million (down 6.68% YoY), and the FY2025 annual result was $171.0 million, down 1.24% from the prior year.
  • Operating Expenses fell to $29.1 million in Q1 2026 per AMRN's latest filing, from $29.5 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $106.5 million in Q2 2022 and troughed at $29.1 million in Q1 2026.
  • A 5-year average of $56.2 million and a median of $50.0 million in 2023 frame the typical range for Operating Expenses.
  • The sharpest annual moves came in 2022 and 2025: Operating Expenses sank 45.55% in 2022, then jumped 53.25% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $73.2 million in 2022, then slumped by 31.74% to $50.0 million in 2023, then retreated by 14.02% to $43.0 million in 2024, then tumbled by 31.34% to $29.5 million in 2025, then fell by 1.33% to $29.1 million in 2026.
  • Business Quant data shows AMRN's Operating Expenses at $29.1 million in Q1 2026, $29.5 million in Q4 2025, and $33.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -5.14 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 6.72 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 9.59 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 11.01 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 19.82 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 5.95 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 4.37 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 5.50 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 8.25 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn 29.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 29.10 Mn
Dec 31, 2025 29.49 Mn
Sep 30, 2025 33.31 Mn
Jun 30, 2025 66.35 Mn
Mar 31, 2025 41.89 Mn
Dec 31, 2024 42.96 Mn
Sep 30, 2024 41.44 Mn
Jun 30, 2024 43.29 Mn
Mar 31, 2024 45.49 Mn
Dec 31, 2023 49.96 Mn
Sep 30, 2023 51.27 Mn
Jun 30, 2023 66.63 Mn
Mar 31, 2023 65.27 Mn
Dec 31, 2022 73.19 Mn
Sep 30, 2022 68.00 Mn
Jun 30, 2022 106.46 Mn
Mar 31, 2022 100.70 Mn
Dec 31, 2021 97.72 Mn
Sep 30, 2021 124.90 Mn
Jun 30, 2021 113.56 Mn